Intel stock today: INTC dips into 2026 as Nvidia’s $5B stake keeps focus on what’s nextNEW YORK, January 1, 2026, 10:13 ET — Market closed
1 January 2026
1 min read

Intel stock today: INTC dips into 2026 as Nvidia’s $5B stake keeps focus on what’s nextNEW YORK, January 1, 2026, 10:13 ET — Market closed

  • Intel shares last closed down about 1% at $36.90 in the final U.S. session of 2025.
  • Nvidia has completed a $5 billion private placement purchase of Intel stock, an SEC filing showed. 1
  • Traders are watching chip-sector sentiment and late-January earnings timing as markets reopen Friday. 2

Intel Corp (INTC.O) shares closed down about 1% at $36.90 on Wednesday, the final trading session of 2025, with U.S. markets shut on Thursday for New Year’s Day. 2

The move matters because Intel heads into 2026 after a sharp run-up in 2025, leaving less room for missteps as investors look for proof that funding and partnerships can translate into results. 1

That scrutiny has sharpened after Nvidia’s $5 billion investment, which adds cash but also increases Intel’s share count — a dilution risk for existing holders if profits don’t rise fast enough. 1

Intel said in an SEC filing it completed the sale of 214,776,632 shares to Nvidia (NVDA.O) for $5.0 billion in cash, at $23.28 per share. The company said the deal was done as a private placement, meaning the shares were sold outside the public market. 1

U.S. antitrust agencies cleared Nvidia’s investment in Intel earlier in December, according to a Federal Trade Commission notice cited by Reuters. 3

Intel’s late-December trading has also tracked a softer tone in equities into year-end. The S&P 500 fell 0.74% and the Nasdaq Composite lost 0.76% in the final session of 2025, Reuters reported. “It’s perfectly fine in any bull market to have moments of cost,” said Giuseppe Sette, co-founder and president of Reflexivity, pointing to profit-taking when liquidity is low. 4

Chip stocks broadly weakened alongside the market. The iShares Semiconductor ETF fell 1.2%, while the Nasdaq-100 tracking QQQ slipped 0.8%. Nvidia and Advanced Micro Devices (AMD.O) each eased about 0.5%, while U.S.-listed shares of Taiwan Semiconductor Manufacturing rose 1.4%.

Intel traded between $36.82 and $38.01 on Wednesday, according to market data. The stock ended 2025 about 15% below its 52-week high of $44.02 reached on Dec. 3, MarketWatch data showed. 5

For investors, the next test is whether Intel can show momentum in core PC and data-center chips while advancing its bid to rebuild manufacturing competitiveness — a pressure point as rivals such as AMD and Taiwan’s TSMC set the pace in key markets. 3

Before the next session, the focus shifts to Friday’s reopening after the holiday closure. Year-start flows often bring sharp moves in large-cap tech and semiconductors, especially after a year-end slide. 2

Earnings are the next major scheduled catalyst. Yahoo Finance’s earnings calendar lists Intel for Jan. 29 after the close, while Nasdaq’s earnings page also shows Jan. 29 as an estimate based on prior reporting patterns. 6

From a trading standpoint, Intel’s near-term levels are straightforward: bulls will want to see the shares reclaim the $38 area from Wednesday’s range, while bears will watch whether support around $37 holds as markets resume.

Stock Market Today

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
New York, Feb 7, 2026, 09:35 EST — Market closed. Roivant Sciences Ltd shares leapt on Friday after the company reported positive mid-stage results for its immune-modulating drug brepocitinib in a rare skin disease, and paired the readout with its quarterly financial update. The Nasdaq-listed stock closed up 22.4% at $25.82, leaving traders to gauge whether the move has legs when U.S. markets reopen on Monday, Feb. 9. It matters because Roivant is trying to turn a late-stage pipeline into approvals, and the market has been quick to reward biotechs that can show clean efficacy in controlled trials. The company
Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

Amazon stock tumbles on $200 billion AI spend plan — what to know before Monday

7 February 2026
Amazon shares fell 5.6% to $210.32 on Friday after the company projected about $200 billion in 2026 capital expenditures, triggering investor concern over AI spending. The stock had already dropped 11.5% after-hours Thursday. Amazon forecast Q1 net sales of $173.5–$178.5 billion and operating income of $16.5–$21.5 billion. Analyst Gil Luria downgraded Amazon, citing rising investment as its cloud lead narrows.
AMD stock jumps 8% in chip rebound — what investors are watching before Monday

AMD stock jumps 8% in chip rebound — what investors are watching before Monday

7 February 2026
AMD shares jumped 8.2% to $208.44 Friday, trading on heavy volume as chip stocks rebounded and the Dow closed above 50,000 for the first time. The Philadelphia Semiconductor Index rose 5.7% after Amazon’s AI spending plans lifted sector estimates. Nvidia’s CEO cited surging AI chip demand. AMD’s rally followed a weak revenue outlook earlier in the week.
Nike stock today: NKE rises after CEO Elliott Hill buys $1 million of shares
Previous Story

Nike stock today: NKE rises after CEO Elliott Hill buys $1 million of shares

Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus
Next Story

Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus

Go toTop